XAGE

Longevity Health Holdings Inc. XAGE

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode XAGE CELU HEPA ZVSA CCM ADTX IVF SISI LIXT SCNI
6M -87.84 % 32.32 % -81.12 % -80.52 % 60.47 % -76.93 % -86.04 % -98.29 % 243.90 % -28.13 %
YTD -97.21 % -1.36 % -99.74 % -87.27 % 6.98 % -98.96 % -86.04 % -99.26 % 90.54 % -59.88 %
1Y -96.93 % -21.94 % -99.78 % -93.86 % -19.39 % -99.82 % -86.04 % -99.64 % 140.34 % -61.88 %
3Y -99.80 % -90.36 % -99.99 % -100.00 % -59.41 % -100.00 % -86.04 % -99.99 % -21.67 % -97.49 %
5Y -99.80 % -97.94 % -100.00 % -100.00 % -59.41 % -100.00 % -86.04 % -100.00 % -93.97 % -99.97 %
10Y -99.80 % -97.79 % -100.00 % -100.00 % -86.86 % -100.00 % -86.04 % -100.00 % -55.94 % -99.65 %
From the beginning -99.80 % -97.79 % -100.00 % -100.00 % -91.73 % -100.00 % -86.04 % -100.00 % -99.84 % -99.72 %

Dividend

Concord Medical Services Holdings Limited